Sucampo Pharmaceuticals, Inc. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/29865c06-3b41-4438-986d-dcbf67347c70/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2016 | $128.8M | 2016-01-01 – 2016-12-31 | evidence 0001171843-17-001354 |
| FY 2015 | $66.3M | 2015-01-01 – 2015-12-31 | evidence 0001171843-16-008505 |
| FY 2014 | $33.3M | 2014-01-01 – 2014-12-31 | evidence 0001171843-15-001318 |
| FY 2013 | $89.6M | 2013-01-01 – 2013-12-31 | evidence 0001171843-14-001213 |
| FY 2012 | $81.5M | 2012-01-01 – 2012-12-31 | evidence 0001144204-13-015904 |
| FY 2011 | $54.8M | 2011-01-01 – 2011-12-31 | evidence 0001144204-12-015229 |
| FY 2010 | $61.9M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-015229 |
| FY 2009 | $67.4M | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-015229 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Sucampo Pharmaceuticals, Inc. — all facts · Net Income · Operating Income